Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose M Rubio

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Biological Psychiatry|May 16, 2025
Mechanistic and Predictive Implications of Transdiagnostic Features of the ConnectomeJose M Rubio, Elvisha Dhamala
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2025
Persistent brain network signatures in psychosis: implications for diagnosis, prognosis, and treatmentElvisha Dhamala, Jose M Rubio
Evidence-Based Mental Health|January 19, 2017
Reduced all-cause mortality with antipsychotics and antidepressants compared to increased all-cause mortality with benzodiazepines in patients with schizophrenia observed in naturalistic treatment settingsJose M Rubio, Christoph U Correll
The Journal of Clinical Psychiatry|April 11, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic DisordersJose M Rubio, Christoph U Correll
Evidence-Based Mental Health|July 13, 2018
Clozapine and long-acting injectable antipsychotics reduce hospitalisation and treatment failure risk in patients with schizophreniaJose M Rubio, Christoph U Correll
The American Journal of Psychiatry|June 10, 2026
A Proposed Expansion of the Definition of Treatment-Resistant SchizophreniaJose M Rubio, John M Kane
Therapeutic Advances in Psychopharmacology|March 10, 2023
The place of long-acting injectable antipsychotics in the treatment of schizophreniaJohn M Kane, Jose M Rubio
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
The pharmacological treatment of schizophrenia: How far have we come?Jose M Rubio, John M Kane
The Journal of Clinical Psychiatry|December 1, 2021
How to Make an Effective Offer of ClozapineJose M Rubio, John M Kane
NPJ Schizophrenia|October 13, 2017
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?Jose M Rubio, John M Kane
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Biological Psychiatry|May 16, 2025
Mechanistic and Predictive Implications of Transdiagnostic Features of the ConnectomeJose M Rubio, Elvisha Dhamala
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 5, 2025
Persistent brain network signatures in psychosis: implications for diagnosis, prognosis, and treatmentElvisha Dhamala, Jose M Rubio
Evidence-Based Mental Health|January 19, 2017
Reduced all-cause mortality with antipsychotics and antidepressants compared to increased all-cause mortality with benzodiazepines in patients with schizophrenia observed in naturalistic treatment settingsJose M Rubio, Christoph U Correll
The Journal of Clinical Psychiatry|April 11, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic DisordersJose M Rubio, Christoph U Correll
Evidence-Based Mental Health|July 13, 2018
Clozapine and long-acting injectable antipsychotics reduce hospitalisation and treatment failure risk in patients with schizophreniaJose M Rubio, Christoph U Correll
The American Journal of Psychiatry|June 10, 2026
A Proposed Expansion of the Definition of Treatment-Resistant SchizophreniaJose M Rubio, John M Kane
Therapeutic Advances in Psychopharmacology|March 10, 2023
The place of long-acting injectable antipsychotics in the treatment of schizophreniaJohn M Kane, Jose M Rubio
PCN Reports : Psychiatry and Clinical Neurosciences|June 13, 2024
The pharmacological treatment of schizophrenia: How far have we come?Jose M Rubio, John M Kane
The Journal of Clinical Psychiatry|December 1, 2021
How to Make an Effective Offer of ClozapineJose M Rubio, John M Kane
NPJ Schizophrenia|October 13, 2017
Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?Jose M Rubio, John M Kane
Pageof 8